From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more
Resources​
Programs​
Education

Back

Australasian Contact Tracing Guidelines

First published:

1997

Last published:

October 2026
View Website

Overview

Draft: Australian Contact Tracing Guidelines (2026)

The Australian Contact Tracing Guidelines (2026) supersede the Australasian Contact Tracing Guidelines (2022) and are now available for public consultation in accordance with Framework 1: ASHM Guidelines.

Following the public consultation period, the web version of these guidelines will be integrated throughout the Australian STI Management Guidelines, replacing existing contact tracing content. The Australasian Contact Tracing Guidelines (2022) website will subsequently be archived. The standalone PDF version is provided for those who prefer to download, print or reference the guidelines as a complete document.

ASHM welcomes feedback from clinical experts, community representatives, professional bodies, organisations and interested individuals.

Feedback is due by Wednesday, 2 December 2026.

Use the website link above to access the draft guideline and consultation survey.